FGFRs play an important yet understudied role in breast cancer and are deregulated in a significant percentage of the oestrogen/progesterone receptor (ER/PR) and triple‐negative breast cancer (TNBC) subtypes of breast cancer (Babina & Turner, 2017; Navid et␣al,2020). The gene discussed is PGR; the disease is breast carcinoma.